AR095033A1 - MODULATORS BENZOIMIDAZOL-2-IL PYRIMIDINE MODULAR HISTAMINE RECEPTOR H₄ - Google Patents

MODULATORS BENZOIMIDAZOL-2-IL PYRIMIDINE MODULAR HISTAMINE RECEPTOR H₄

Info

Publication number
AR095033A1
AR095033A1 ARP140100731A ARP140100731A AR095033A1 AR 095033 A1 AR095033 A1 AR 095033A1 AR P140100731 A ARP140100731 A AR P140100731A AR P140100731 A ARP140100731 A AR P140100731A AR 095033 A1 AR095033 A1 AR 095033A1
Authority
AR
Argentina
Prior art keywords
benzoimidazol
modulators
pyrimidine
modular
histamine receptor
Prior art date
Application number
ARP140100731A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR095033A1 publication Critical patent/AR095033A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Benzoimidazol-2-il pirimidinas, métodos de purificación de estas, y composiciones farmacéuticas y métodos para el tratamiento de estados patológicos, trastornos y afecciones mediados por la actividad del receptor H₄ que incluyen alergia, asma, enfermedades autoinmunes y prurito. Reivindicación 1: Un hemitartrato tetrahidratado de [5-(4,6-dimetil-1H-benzoimidazol-2-il)-4-metil-pirimidin-2-il]-[3-(1-metil-piperidin-4-il)-propil]-amina de fórmula (1).Benzoimidazol-2-yl pyrimidines, purification methods thereof, and pharmaceutical compositions and methods for the treatment of pathological conditions, disorders and conditions mediated by the activity of the H₄ receptor that include allergy, asthma, autoimmune diseases and pruritus. Claim 1: A [5- (4,6-dimethyl-1H-benzoimidazol-2-yl) -4-methyl-pyrimidin-2-yl] - [3- (1-methyl-piperidin-4-yl) tetrahydrate hemitartrate ) -propyl] -amine of formula (1).

ARP140100731A 2013-03-06 2014-03-06 MODULATORS BENZOIMIDAZOL-2-IL PYRIMIDINE MODULAR HISTAMINE RECEPTOR H₄ AR095033A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361773706P 2013-03-06 2013-03-06

Publications (1)

Publication Number Publication Date
AR095033A1 true AR095033A1 (en) 2015-09-16

Family

ID=56119066

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100731A AR095033A1 (en) 2013-03-06 2014-03-06 MODULATORS BENZOIMIDAZOL-2-IL PYRIMIDINE MODULAR HISTAMINE RECEPTOR H₄

Country Status (2)

Country Link
AR (1) AR095033A1 (en)
MA (1) MA38451A1 (en)

Also Published As

Publication number Publication date
MA38451A1 (en) 2017-07-31

Similar Documents

Publication Publication Date Title
DOP2016000027A (en) MODULATORS BENZOIMIDAZOL-2-ILPIRIMIDINAS OF THE H4 HISTAMINE RECEIVER
NI200800260A (en) BENZOIMIDAZOLE - 2 - IL PYRIMIDINES AND PIRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR
CL2013003051A1 (en) Compounds derived from pyrazolo (4.3-d) pyrimidines, kinase inhibitors; pharmaceutical composition; and use for the treatment of diseases and disorders of the respiratory system
NI200900159A (en) 2-AMINOPYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR.
BR112016025423A2 (en) compounds and compositions as toll-7 receptor agonists
CL2012001073A1 (en) Compounds derived from pyrido [4,3-d] pyrimidin-5-one, their pharmaceutical compositions and their use as kinase inhibitors to treat asthma, COPD, ulcerative colitis, bronchitis, lupus, breast cancer, Alzheimer's disease, Alzheimer's disease parkinson's, osteoporosis, multiple sclerosis, diabetes, eye disorders, restenosis, inflammatory diseases.
EA201790519A1 (en) THERAPEUTIC CONNECTIONS AS INTEGRATORS OF OREXIN-1 RECEPTOR
ECSP17010481A (en) NEW 2,5-SUBSTITUTED PYRIMIDINES
PH12016501624A1 (en) 1,2-substituted cyclopentanes as orexin receptor antagonists
CR20140257A (en) NEW 2H-INDAZOLS AS ANTAGONISTS OF THE EP2 RECEIVER
MX341577B (en) Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors.
DOP2015000214A (en) NEW INHIBITING COMPOUNDS OF TYPE 10A PHOSPHODIESTERASE
CO2017001523A2 (en) Novel 2,5-substituted pyrimidines
UY33529A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES?
PH12015500322B1 (en) Tris(hetero)arylpyrazoles and use thereof
MX2015002514A (en) Antagonists of chemokine receptors.
AR095033A1 (en) MODULATORS BENZOIMIDAZOL-2-IL PYRIMIDINE MODULAR HISTAMINE RECEPTOR H₄
CU20140058A7 (en) NEW 2H-INDIZOLS AS ANTAGONISTS OF THE EP-2 RECEIVER
PE20151069A1 (en) NEW TYPE 10A PHOSPHODIESTERASE INHIBITING COMPOUNDS

Legal Events

Date Code Title Description
FB Suspension of granting procedure